Infectious Diseases – News and Features

Researchers involved in the Influenza Genome Sequencing Project have sequenced the genomes of more than 2,000 influenza viruses.

Vitalea recieves NIAID grant to develop and test assays that can be applied to children and neonates to quantify intracellular uptake of antiretroviral drugs.

With three human RNAi gene therapy trials now under way, the technique may be among the first to find widespread use for treating human diseases.

Cepheid expands its PCR based molecular diagnostics product area by acquiring Sangtec Molecular Diagnostics AB from the Nycomed-owned ALTANA Pharma AG.

Copernicus Therapeutics will utilize the funds for the development its non-viral gene therapy for cystic fibrosis.

QIAGEN acquires two new licenses from Roche and Ortho Clinical Diagnostics to expand its technology portfolio targeting molecular diagnostics.

Cell Therapeutics plans to form a new company to develop a Genetic Polymer™ technology to speed the manufacture, development and commercialization of biopharmaceuticals.

Argos Therapeutics initiates a Phase 1/2 clinical trial to test the immunologic activity and safety of its AGS-004 in HIV-infected adults.

European companies and universities will develop new technologies for large-scale extraction of a natural antimalarial ‘wonder drug’ over the next 12 months.

Duke University researchers have created a three-dimensional fabric scaffold that could improve the ability of physicians to repair damaged joints with the patient's own stem cells.